Long-term cardiovascular outcomes and events by New York Heart Association class in patients with obstructive hypertrophic cardiomyopathy in England

Back

HFA Premium Access

Long-term cardiovascular outcomes and events by New York Heart Association class in patients with obstructive hypertrophic cardiomyopathy in England

Session: Myocardial disease - hypertrophic cardiomyopathy 2

Topic: Hypertrophic Cardiomyopathy

Speaker: Doctor B. Sandler (GB) Mr M. Hurst (London, GB)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speakers

Doctor Belinda Sandler

(United Kingdom of Great Britain & Northern Ireland)

0 follower

Mr Michael Hurst

Bristol Myers Squibb, London (United Kingdom of Great Britain & Northern Ireland)

1 presentation

0 follower

6 more presentations in this session

Betablockers or calcium channel blockers in hypertrophic cardiomyopathy

Speaker: Doctor G. Pinto (Milan, IT)

Access

Abstract

Slides

Myocardial extracellular space expansion and diastolic function is related to QRS-T angle in patients with hypertrophic cardiomyopathy

Speaker: Doctor H. Chung (Seoul, KR)

Access

Abstract

Slides

All-cause mortality in hypertrophic cardiomyopathy (HCM) compared to the general population in England and the US

Speaker: Doctor M. Tome Esteban (London, GB)

Access

Abstract

Slides

Septal microsphere embolization in hypertrophic obstructive cardiomyopathy: a quindecennial single-center experience

Speaker: Doctor E. Alyaydin (Zurich, CH)

Access

Abstract

Slides

No variant tranythyretin amyloidosis is found in a large non-red-flag selected cardiomyopathy population

Speaker: Doctor H. Takacs (Szeged, HU)

Access

Abstract

Slides

Access the full session

Myocardial disease - hypertrophic cardiomyopathy 2

Speakers: Doctor B. Sandler, Mr M. Hurst, Doctor G. Pinto, Doctor H. Chung, Doctor M. Tome Esteban...

Access

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources